Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms
K. Kai McKinstry, Tara M. Strutt, Yi Kuang, Deborah M. Brown, Stewert Sell, Richard W. Dutton, Susan L. Swain
K. Kai McKinstry, Tara M. Strutt, Yi Kuang, Deborah M. Brown, Stewert Sell, Richard W. Dutton, Susan L. Swain
View: Text | PDF
Research Article

Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms

  • Text
  • PDF
Abstract

Memory CD4+ T cells combat viral infection and contribute to protective immune responses through multiple mechanisms, but how these pathways interact is unclear. We found that several pathways involving memory CD4+ T cells act together to effectively clear influenza A virus (IAV) in otherwise unprimed mice. Memory CD4+ T cell protection was enhanced through synergy with naive B cells or CD8+ T cells and maximized when both were present. However, memory CD4+ T cells protected against lower viral doses independently of other lymphocytes through production of IFN-γ. Moreover, memory CD4+ T cells selected for epitope-specific viral escape mutants via a perforin-dependent pathway. By deconstructing protective immunity mediated by memory CD4+ T cells, we demonstrated that this population simultaneously acts through multiple pathways to provide a high level of protection that ensures eradication of rapidly mutating pathogens such as IAV. This redundancy indicates the need for reductionist approaches for delineating the individual mechanisms of protection mediated by memory CD4+ T cells responding to pathogens.

Authors

K. Kai McKinstry, Tara M. Strutt, Yi Kuang, Deborah M. Brown, Stewert Sell, Richard W. Dutton, Susan L. Swain

×

Figure 7

Memory CD4+ T cell protection requires IFN-γ in the absence of host lymphocytes.

Options: View larger image (or click on image) Download as PowerPoint
Memory CD4+ T cell protection requires IFN-γ in the absence of host lymp...
5 × 106 WT or Ifng–/– memory HNT cells were transferred to unprimed SCID hosts, then infected with 2,500 EID50 PR8. Recipients of WT cells were treated with 500 μg of isotype or anti–IFN-γ neutralizing ab throughout the infection. (A) Survival, (B) weight loss, and (C) mean viral titers (horizontal bar) at 9 dpi are shown for at least n = 5/group (circles) (1 of 2 separate experiments, *P < 0.005; **P < 0.005; ****P < 0.0001). (D) SCID recipients of 5 × 106 WT or Ifng–/– memory HNT cells were challenged with 50 EID50 PR8 and weight loss determined (n = 6/group). SCID recipients of Ifng–/– memory HNT cells were also reconstituted with no additional cells, unprimed Ifng–/– B cells, or unprimed Ifng–/– CD8 T cells and (E) survival and (F) weight loss determined. n = 5/group (1 of 2 separate experiments).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts